Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
PatSnap Eureka Desktop
NEWAnalytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisOpen Platform
NEWProfessional Services
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
Frontier
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report Deep patent analysis of tezepelumab: CDR sequences, epitope binding data, Fc engineering for half-life extension, and structural differentiation from earlier anti-TSLP biologics.
Article | Report Long-term DESTINY-Breast04 data show T-DXd cuts death risk by 31–42% vs TPC across HR+, HR−, and ER-subgroups in HER2-low metastatic breast cancer.
Article | Report How to engineer polymer composites with high thermal conductivity and electrical insulation for power electronics: filler selection, hybrid architectures, and breakdown voltage strategies.
Article | Report PEM, alkaline, and solid oxide electrolyzer critical materials in 2026: iridium scarcity, patent trends, and the innovation pipeline shaping green hydrogen at scale.
Article | Report How to select and optimize polymer resin systems for low-dielectric 5G copper clad laminates. Dk/Df targets, filler design, and thermal stability strategies.
Article | Report Iptacopan and danicopan vs eculizumab and ravulizumab in PNH: mechanistic rationale for proximal vs terminal complement inhibition and EVH control evidence.
Article | Report How do sulfide, oxide, and polymer solid-state electrolytes compare in 2026? Ionic conductivity, stability, and patent trends analysed from 539 filings.
Article | Report Silicone, DLC, sol-gel ceramics, bio-based polymers, and plasma films mapped against PFAS performance benchmarks and 2025–2027 regulatory deadlines.
Article | Report How to design high-entropy alloy compositions with simultaneous high strength and ductility—covering ML-driven screening, CALPHAD phase prediction, and thermomechanical processing.
Article | Report China controls ~90% of rare earth processing and ~85% of NdFeB magnet output. Discover how export controls, cerium alternatives, and Western capacity buildouts are reshaping the global magnet supply chain.
Article | Report How to engineer LFP cathode composition and particle morphology to simultaneously improve cycle life, rate performance, and thermal stability for EV batteries.
Article | Report Thermo Fisher leads mass spectrometry with 341 patents; Danaher counters with 377 across subsidiaries. Explore divergent R&D strategies shaping life science instruments 2015–2026.
Article | Report Bimekizumab vs secukinumab: head-to-head trial data, patent evidence, and mechanistic rationale for dual IL-17A/F blockade across psoriasis, axSpA, and HS.
Article | Report How selective androgen receptor degraders (SARDs) use the ubiquitin-proteasome system to overcome LBD mutations and AR-V7 splice variants driving mCRPC resistance.
Article | Report Deep analysis of Novartis patent WO2015009616A1: Iptacopan Factor B inhibitor binding pocket interactions, selectivity SAR, ADME/PK, and piperidine vs pyrrolidine scaffold comparison.